A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.
Merz on Friday announced the introduction of new packaging for its Mederma Stretch Marks Therapy that "addresses major retail challenges."
Merz North America on Monday named Jim Hartman VP of the Merz Aesthetics business unit, which includes Xeomin, Radiesse and Belotero Balance.
Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.
Merz has promoted one of its executives to serve as VP and chief compliance officer.